First human trial launches for new Cell-Based attack on tough pancreatic cancer
NCT ID NCT07425483
Summary
This is a first-in-human study to test the safety and early effectiveness of a new cell therapy called CAR-NK cells in patients with advanced pancreatic cancer. The study will enroll a small group of patients whose cancer has progressed despite standard treatments. The main goal is to see if the treatment is safe and well-tolerated, while also looking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Changhai Hospital
RECRUITINGShanghai, 200433, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.